On January 24, 2013, Wang, Xueqing; Meyer, Michael; Yao, Betty; Guo, Tao; Wei, Guo Pingrobert; Wang, Lijuan Jane published a patent.Name: 4-Oxochroman-6-carbonitrile The title of the patent was Preparation of 1,6-naphthyridine derivatives as chemokine receptor antagonists. And the patent contained the following:
The invention relates to 1,6-naphthyridine derivatives of formula I and pharmaceutically acceptable salts, solvates and prodrugs thereof as chemokine receptor antagonists; their preparation and use in the treatment of pain. Compounds of formula I wherein X1 is CR1 and N; X2 is CR2 and N; X3 is CR3 and N; R1, R2 and R3 are independently H, CN, halo, etc.; G1 is NR4R5, substituted pyridinyl, etc.; R4 is H,(halo)alkyl, alkoxyalkyl, etc.; R5 is (un)substituted heterocyclyl, Ph, naphthyl, cycloalkyl, etc.; and pharmaceutically acceptable salts, solvates and prodrugs thereof, are claimed. Example compound II 鈥?succinate was prepared by a multistep procedure (procedure given). All the invention compounds were evaluated for their chemokine receptor antagonistic activity. From the assay, it was determined that example compound II 鈥?succinate exhibited Kb value ranged from 0.003 渭M to 0.006 渭M. The experimental process involved the reaction of 4-Oxochroman-6-carbonitrile(cas: 138801-92-0).Name: 4-Oxochroman-6-carbonitrile
The Article related to naphthyridine preparation chemokine receptor antagonist treatment pain, Heterocyclic Compounds (More Than One Hetero Atom): Fused-Ring Systems With Two Or More Hetero Atoms, No More Than One Hetero Atom Per Ring and other aspects.Name: 4-Oxochroman-6-carbonitrile
Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts